Walgreens says it will sell the abortion pill, a day after the FDA changed its rules to allow retail pharmacies to fill prescriptions for the controversial drug
The chain says it will sell the abortion pill mifepristone in certain stores, a day after the FDA changed its rules to allow retail pharmacies to fill prescriptions
Mifepristone tablet packages—a drug that blocks a hormone needed for pregnancy and is FDA-approved for use up to 10 weeks in pregnancy.Walgreens Boots Alliance Inc. is the first major national pharmacy chain to say it plans to dispense the abortion pill underThe new rules, issued Tuesday, allow any pharmacy to become certified to dispense mifepristone, the
a hormone needed for pregnancy and is FDA-approved for use up to 10 weeks in pregnancy. Until the changes, the agency had allowed only a handful of mail-order pharmacies and certified doctors to hand out the drug.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Abortion Pills to Be Available More Widely Under New FDA RulesBreaking: An abortion pill will be made more widely available under new FDA rules allowing brick-and-mortar pharmacies to dispense the drug for the first time
Les mer »
Sesame joins the major food allergens list, FDA saysSesame has joined the list of major food allergens defined by law, according to the U.S. Food and Drug Administration.
Les mer »
Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportThe FDA's approval process of Alzheimer’s drug Aduhelm has been deemed “rife with irregularities,” according to a congressional investigation. Here are takeaways from the report.
Les mer »
Evaxion's stock soars after getting FDA approval for mid-stage cancer trialU.S.-listed shares of Evaxion Biotech A/S undefined jumped about 17% in premarket trading on Tuesday after the company said the Food and Drug Administration...
Les mer »
FDA Approves Wegovy (Semaglutide) for Obesity in Teens 12 and UpFDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older.
Les mer »